Inhaled amikacin reduces ventilatory-associated pneumonia
For critically ill patients undergoing mechanical ventilation for at least three days, a three-day course of inhaled amikacin reduces the subsequent burden of ventilatory-associated pneumonia, according to a study published ...
Oct 30, 2023
0
0